The document is an intimation of a scheduled Investor Meet, categorized as a Group meeting to be conducted In-person.
The event is scheduled for Monday, June 08, 2026. The specific time of the meeting was not disclosed in the provided data.
The stated purpose of the event is for general investor engagement, as per the company's scheduled plan for analyst and institutional investor meetings.
The document does not specify if this meeting is scheduled before or after an earnings announcement.
Management participants and their designations were not provided in the disclosure.
The company has not indicated that a presentation, earnings deck, transcript, or recording will be made available from this meeting.
The company has explicitly stated that "No unpublished price sensitive information (UPSI) will be discussed" during this meeting. This is a key compliance declaration.
No financial highlights, guidance references, or presentation summaries were included in this specific announcement.
Additional Notes Section
This is a standalone regulatory letter of intimation. No attachments, such as an invite or investor deck, were mentioned as being included.
No financial data, performance figures, or strategic updates were disclosed in this announcement. The document is purely a schedule intimation and compliance notice.
Logistical details for accessing the meeting (e.g., venue address, dial-in numbers) were not provided in this disclosure.
